518 related articles for article (PubMed ID: 6393391)
1. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
4. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Verstraete M
Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
[No Abstract] [Full Text] [Related]
5. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
6. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Croveri G
Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
[No Abstract] [Full Text] [Related]
7. Drugs in the treatment of thrombo-embolic disease--part I.
Bouchier-Hayes D
Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
[No Abstract] [Full Text] [Related]
8. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
9. Antiplatelet drugs in thromboembolism.
Hirsh J
Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
11. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
12. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
13. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
14. [Treatment with antiplatelet drugs. Current status of knowledge].
Dettori AG; Pini M; Quintavalla R
Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
[No Abstract] [Full Text] [Related]
15. Drug therapy: antiplatelet therapy (second of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
[No Abstract] [Full Text] [Related]
16. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
17. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
18. Treating thromboembolic disease.
Deykin D; Gurewich V; Harker L; Hirsch J
Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
[No Abstract] [Full Text] [Related]
19. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
20. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Harker LA; Hirsh J; Gent M; Genton E
Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
